Aspergillosis in "nonimmunocompromised" critically ill patients (Q43655100)

25 November 2017

title

Aspergillosis in "nonimmunocompromised" critically ill patients (English)

1 reference

25 November 2017

0 references

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

25 November 2017

published in

1 reference

25 November 2017

volume

170

1 reference

25 November 2017

1 reference

25 November 2017

page(s)

580-581

1 reference

Burden of aspergillosis-related hospitalizations in the United States

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

Disseminated aspergillosis in intensive care unit patients: an autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

Glucocorticoids and invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

DNA typing of epidemiologically-related isolates of Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

Outbreak of invasive Aspergillus infection in surgical patients, associated with a contaminated air-handling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

Therapeutic outcome in invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

Echinocandin antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2407004

21 January 2018

Identifiers

DOI

10.1164/RCCM.2407004

1 reference

25 November 2017

1 reference